Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Datexim

Datexim
PRIVATE STATUS
Series A LATEST DEAL TYPE
$1.69M LATEST DEAL AMOUNT
4 INVESTORS
Description

Manufacturer of medical imaging technologies created to detect diseases. The company's medical imaging products deploy its diagnostic assistance solution to its private anatomical pathology laboratories, enabling pathology laboratories to detect diseases quickly and accurately.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 51 Avenue de la Cote de Nacre
  • 14000 Caen
  • France

+33 02 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Datexim’s full profile, request a free trial.

Datexim Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 01-Apr-2019 $1.69M 00.000 Completed Generating Revenue
2. Seed Round 22-Mar-2017 00000 00000 Completed Generating Revenue
1. Accelerator/Incubator 01-May-2009 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Datexim Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Odyssee Venture PE/Buyout Minority 000 0000 000000 0
Normandie Business Angels Angel Group Minority 000 0000 000000 0
Normandie Participations Venture Capital Minority 000 0000 000000 0
Normandie Incubation Accelerator/Incubator Minority 000 0000 000000 0

Datexim Executive Team (5)

Name Title Board
Seat
Contact
Info
Arnaud Renouf Ph.D Co-Founder & President
Jean-Hugues Pruvot Ph.D Co-Founder, President & Manager, Research and Development
Cyril Bazin Ph.D Technical Director
David Lelouvier Advisor

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »